24
Participants
Start Date
May 7, 2018
Primary Completion Date
December 13, 2021
Study Completion Date
December 20, 2023
Denosumab
1mg/kg BW (up to a maximum of 60 mg) SC Q6M
Placebo
SC Q6M placebo
Cliniques Universtaire Saint Luc Universite Catholique de Louvain, Brussels
Medical Centre Synexus Sofia EOOD, Sofia
Perth Childrens Hospital, Nedlands
AI Dupont Hospital for Children, Wilmington
Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Milan
Ataturk Universitesi Tip Fakultesi, Erzurum
Marmara Universitesi Pendik Egitim Arastirma Hastanesi, Istanbul
Ege Universitesi Tip Fakultesi, Izmir
Nationwide Childrens Hospital, Columbus
Metrohealth Medical Center, Cleveland
Indiana University Hospital, Indianapolis
CI Dnipropetrovsk Regional Children Clinical Hospital of Dnipropetrovsk Regional Council, Dnipro
Azienda Ospedaliera Universitaria Meyer, Florence
University of Minnesota Masonic Childrens Hospital Discovery Clinic, Minneapolis
Communal Institution of Healthcare Kharkiv City Clinical Children Hospital 16, Kharkiv
Childrens Hospital of Los Angeles, Los Angeles
Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo, Bogota
FSAI Scientific Center of Childrens Health of MoH of the RF, Moscow
SBEI of HPE First Moscow state medical university na I M Sechenov of MoH of Russian Federation, Moscow
LLC Medical Technologies, Saint Petersburg
KLES Dr Prabhakar Kore Hospital and Medical Research Centre, Belagavi
SBHI of Novosibirsk region City Pediatric Clinical Hospital of Emergency Care, Novosibirsk
Foscal Internacional-Fundacion Oftalmologica de Santander, Floridablanca
Childrens Hospital of Eastern Ontario, Ottawa
Centre Hospitalier Universitaire Sainte Justine, Montreal
Center for Clinical and Basic Research Colombia, Medellín
Gandhi Medical College, Hyderabad
Sir Ganga Ram Hospital, New Delhi
Christian Medical College, Vellore
Azienda Ospedaliera Policlinico Umberto I, Roma
RM Pharma Specialists SA de CV, Mexico City
Instituto Nacional de Salud del Nino, Breña
Centro Especializado de Enfermedades Neoplasicas, Arequipa
Hospital Nacional Alberto Sabogal Sologuren, Callao
Clinica Angloamericana, Lima
Centro de Investigacion Ricardo Palma, Lima
Ankara Universitesi Tip Fakultesi, Ankara
National Childrens Specialized Hospital OHMATDYT, Kyiv
Lead Sponsor
Amgen
INDUSTRY